These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6253394)

  • 1. Leukemogenesis, immune responsiveness, and murine leukemia virus expression in congenic AKR/J mice differing at H-2.
    Johnson DA; Bedigian HG; Cherry M; Meier H
    Infect Immun; 1980 Sep; 29(3):1007-12. PubMed ID: 6253394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of anti-AKR/gross virus cytolytic T lymphocytes in AKR.H-2b:Fv-1b congenic mice: age-dependent conversion to a nonresponder phenotype.
    Green WR
    J Immunol; 1987 Mar; 138(5):1602-6. PubMed ID: 3027182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains.
    Wegmann KW; Blank KJ; Green WR
    Cell Immunol; 1988 May; 113(2):308-19. PubMed ID: 2834071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen: mapping of the locus involved to the I region of the H-2 complex.
    Meruelo D; Deak B; McDevitt HO
    J Exp Med; 1977 Nov; 146(5):1367-79. PubMed ID: 411874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
    White HD; Roeder DA; Green WR
    J Virol; 1994 Feb; 68(2):897-904. PubMed ID: 8289392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes of the H-2 complex regulate the antibody response to murine leukemia virus.
    Vlug A; Schoenmakers HJ; Melief CJ
    J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic T lymphocyte-defined retroviral antigens on normal cells: encoding by the Akv-1 proviral locus.
    Green WR; Graziano RF
    Immunogenetics; 1986; 23(2):106-10. PubMed ID: 3007341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation.
    Rich RF; Green WR
    J Virol; 1996 Jan; 70(1):402-14. PubMed ID: 8523554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of the mechanism of leukemogenesis. II. Characterization of endogenous murine leukemia viruses isolated from AKR thymic epithelial reticulum cell lines.
    Yanagihara K; Hamada K; Seyama T; Imamura N; Yokoro K
    J Virol; 1982 Feb; 41(2):360-6. PubMed ID: 6281454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of anti-AKR/gross murine leukemia virus cytotoxic T lymphocytes (CTL). An analysis of precursor CTL frequencies in the AKR.H-2b and C57BL/6 mouse strains.
    Wegmann KW; Rich RF; Green WR
    J Immunol; 1992 Sep; 149(5):1593-8. PubMed ID: 1324278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW; McMaster JS; Green WR
    J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.